Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
1989479 citationsRussell H. Wiesner, Patricia M. Grambsch et al.Hepatologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Sandra J. Beaver
Since
Specialization
Citations
This map shows the geographic impact of Sandra J. Beaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra J. Beaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra J. Beaver more than expected).
Fields of papers citing papers by Sandra J. Beaver
This network shows the impact of papers produced by Sandra J. Beaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra J. Beaver. The network helps show where Sandra J. Beaver may publish in the future.
Co-authorship network of co-authors of Sandra J. Beaver
This figure shows the co-authorship network connecting the top 25 collaborators of Sandra J. Beaver.
A scholar is included among the top collaborators of Sandra J. Beaver based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Sandra J. Beaver. Sandra J. Beaver is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Porayko, Michael K., Stephen C. Textor, R. A. F. Krom, et al.. (1993). Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.. PubMed. 25(1 Pt 1). 665–8.9 indexed citations
3.
Lindor, Keith D., et al.. (1991). The combination of prednisone and colchicine in patients with primary sclerosing cholangitis.. PubMed. 86(1). 57–61.94 indexed citations
4.
Porayko, Michael K., Russell H. Wiesner, J. Eileen Hay, et al.. (1991). Bone disease in liver transplant recipients: incidence, timing, and risk factors.. PubMed. 23(1 Pt 2). 1462–5.140 indexed citations
Cangemi, John R., Sandra J. Beaver, Jürgen Ludwig, et al.. (1989). Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis.. PubMed. 96(3). 790–4.102 indexed citations
Quigley, Eamonn M.M., Sandra J. Beaver, R H Wiesner, & N. F. LaRusso. (1987). Familial occurrence of liver disease and inflammatory bowel disease in primary sclerosing cholangitis. 2. 1585.3 indexed citations
13.
Lindor, Keith D., Russell H. Wiesner, Jerry A. Katzmann, Nicholas F. LaRusso, & Sandra J. Beaver. (1987). Lymphocyte subsets in primary sclerosing cholangitis. Digestive Diseases and Sciences. 32(7). 720–725.47 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.